You dont have to get screened for gene variants, either
Cancer 10 , 505514 (2010)
Although the detrimental effect of GLP-1 agonists have remained unclear with suggestions of increased risk of some cancers, recent reports in fact suggest a reduced risk of colorectal cancer (CRC)
The analyzed populations represented all randomized patients (Full Analysis Set, FAS) and distinguished a subgroup in line with protocol conduct (full-treatment beyond day 7, venous cord blood collected
[DOI] [PubMed] [Google Scholar] 3.Winiarska-Mieczan A., Baranowska-Wjcik E., Kwiecie M., Grela E.R., Szwajgier D., Kwiatkowska K., Kiczorowska B
My Clinical Perspective as a Board-Certified Bariatric & Weight Loss Specialist Semaglutide has helped many patients achieve meaningful, medically significant weight loss